Viewing Study NCT03925350


Ignite Creation Date: 2025-12-24 @ 5:24 PM
Ignite Modification Date: 2026-02-17 @ 6:13 PM
Study NCT ID: NCT03925350
Status: UNKNOWN
Last Update Posted: 2021-10-22
First Post: 2019-03-15
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Efficacy and Safety Study of Niraparib in Melanoma With Genetic Homologous Recombination (HR) Mutation
Sponsor: California Pacific Medical Center Research Institute
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Metastatic Melanoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Homologous recombination (HR) View
None Mutation View
None Niraparib View
None PARP inhibitor View